Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
Grey Matter Neurosciences
Grey Matter Neurosciences secures $14M for Alzheimer's Disease
By
Anthony Vecchione
|
02:56 pm |
January 28, 2025